Vaxneuvance
Trade Name: Vaxneuvance
Generic Name: Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)
Valid
Registration Number
2208234020
Registration Year
2023
Drug Type
Biological
Legal Status
Prescription
Detailed Information
Comprehensive information about this SFDA approval including dosage forms, packaging, and storage conditions.
Dosage and Strength Information
Suspension for injection in pre-filled syringe
64µ/ml
Intramuscular use
Pre-filled syringe
Storage and Shelf Life
Store in a refrigerator (2°C – 8°C), do not freeze
36 Months
ATC Classification
J07AL02